Injections of antibodies against amyloid protein have been able to reverse a form of Alzheimer's disease in mice. This is important because (1) it provides additional evidence that amyloid is indeed the causative agent of Alzheimer's (as many have long suspected) and not just a side effect of the disease, and (2) provides an potentially valuable direction for treatment of the disease in humans.